| Dr Robert J Rookstool, MD | |
|
1211 24th Street, Island Hospital, Anacortes, WA 98221-4927 | |
| (360) 299-1311 | |
| Not Available |
| Full Name | Dr Robert J Rookstool |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 36 Years |
| Location | 1211 24th Street, Anacortes, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154397818 | NPI | - | NPPES |
| 5694RO | Other | WA | BSWA |
| 8161531 | Medicaid | WA | |
| 6075RO | Other | WA | BSWA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD00032276 (Washington) | Primary |
| 207Q00000X | Family Medicine | MD00032276 (Washington) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Whidbeyhealth Medical Center | Coupeville, WA | Hospital |
| Willapa Harbor Hospital | South bend, WA | Hospital |
| Lake Chelan Community Hospital | Chelan, WA | Hospital |
| Island Hospital | Anacortes, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Emergency Physicians Llc | 3476462334 | 186 |
| Pacific County Hospital District 2 | 8224939301 | 14 |
| Whidbey Island Public Hospital District | 1658280680 | 73 |
News Archive
Research at New York University is paving the way for a breakthrough that may prevent brain damage in civilians and military troops exposed to poisonous chemicals-particularly those in pesticides and chemical weapons.
Signalife, Inc. has announced that the United States Patent and Trademark Office has awarded the Company a new and important patent entitled "System For, And Method Of, Monitoring Heartbeats Of A Patient". The patent, which covers 37 claims, will enhance the Company's ability to develop new proprietary products.
According to data from the 2005 and 2016 American College of Rheumatology Workforce Studies, a significant increase in the demand for rheumatologists is expected in the coming years. However, the number of trained rheumatologists is declining.
Marshall Edwards today announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anti-cancer drug, phenoxodiol, fast track status for its intended use in patients with hormone- refractory prostate cancer (HRPC).
› Verified 3 days ago
| Entity Name | Chelan County Public Hospital District No 2 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578568853 PECOS PAC ID: 9133027360 Enrollment ID: O20031226000201 |
News Archive
Research at New York University is paving the way for a breakthrough that may prevent brain damage in civilians and military troops exposed to poisonous chemicals-particularly those in pesticides and chemical weapons.
Signalife, Inc. has announced that the United States Patent and Trademark Office has awarded the Company a new and important patent entitled "System For, And Method Of, Monitoring Heartbeats Of A Patient". The patent, which covers 37 claims, will enhance the Company's ability to develop new proprietary products.
According to data from the 2005 and 2016 American College of Rheumatology Workforce Studies, a significant increase in the demand for rheumatologists is expected in the coming years. However, the number of trained rheumatologists is declining.
Marshall Edwards today announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anti-cancer drug, phenoxodiol, fast track status for its intended use in patients with hormone- refractory prostate cancer (HRPC).
› Verified 3 days ago
| Entity Name | Pacific County Hospital District 2 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295708683 PECOS PAC ID: 8224939301 Enrollment ID: O20040120000991 |
News Archive
Research at New York University is paving the way for a breakthrough that may prevent brain damage in civilians and military troops exposed to poisonous chemicals-particularly those in pesticides and chemical weapons.
Signalife, Inc. has announced that the United States Patent and Trademark Office has awarded the Company a new and important patent entitled "System For, And Method Of, Monitoring Heartbeats Of A Patient". The patent, which covers 37 claims, will enhance the Company's ability to develop new proprietary products.
According to data from the 2005 and 2016 American College of Rheumatology Workforce Studies, a significant increase in the demand for rheumatologists is expected in the coming years. However, the number of trained rheumatologists is declining.
Marshall Edwards today announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anti-cancer drug, phenoxodiol, fast track status for its intended use in patients with hormone- refractory prostate cancer (HRPC).
› Verified 3 days ago
| Entity Name | Whidbey Island Public Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710927231 PECOS PAC ID: 1658280680 Enrollment ID: O20040210000761 |
News Archive
Research at New York University is paving the way for a breakthrough that may prevent brain damage in civilians and military troops exposed to poisonous chemicals-particularly those in pesticides and chemical weapons.
Signalife, Inc. has announced that the United States Patent and Trademark Office has awarded the Company a new and important patent entitled "System For, And Method Of, Monitoring Heartbeats Of A Patient". The patent, which covers 37 claims, will enhance the Company's ability to develop new proprietary products.
According to data from the 2005 and 2016 American College of Rheumatology Workforce Studies, a significant increase in the demand for rheumatologists is expected in the coming years. However, the number of trained rheumatologists is declining.
Marshall Edwards today announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anti-cancer drug, phenoxodiol, fast track status for its intended use in patients with hormone- refractory prostate cancer (HRPC).
› Verified 3 days ago
| Entity Name | Northwest Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235172370 PECOS PAC ID: 3476462334 Enrollment ID: O20041214000892 |
News Archive
Research at New York University is paving the way for a breakthrough that may prevent brain damage in civilians and military troops exposed to poisonous chemicals-particularly those in pesticides and chemical weapons.
Signalife, Inc. has announced that the United States Patent and Trademark Office has awarded the Company a new and important patent entitled "System For, And Method Of, Monitoring Heartbeats Of A Patient". The patent, which covers 37 claims, will enhance the Company's ability to develop new proprietary products.
According to data from the 2005 and 2016 American College of Rheumatology Workforce Studies, a significant increase in the demand for rheumatologists is expected in the coming years. However, the number of trained rheumatologists is declining.
Marshall Edwards today announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anti-cancer drug, phenoxodiol, fast track status for its intended use in patients with hormone- refractory prostate cancer (HRPC).
› Verified 3 days ago
| Entity Name | Chelan County Public Hospital District No 2 |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1578568853 PECOS PAC ID: 9133027360 Enrollment ID: O20061104000289 |
News Archive
Research at New York University is paving the way for a breakthrough that may prevent brain damage in civilians and military troops exposed to poisonous chemicals-particularly those in pesticides and chemical weapons.
Signalife, Inc. has announced that the United States Patent and Trademark Office has awarded the Company a new and important patent entitled "System For, And Method Of, Monitoring Heartbeats Of A Patient". The patent, which covers 37 claims, will enhance the Company's ability to develop new proprietary products.
According to data from the 2005 and 2016 American College of Rheumatology Workforce Studies, a significant increase in the demand for rheumatologists is expected in the coming years. However, the number of trained rheumatologists is declining.
Marshall Edwards today announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anti-cancer drug, phenoxodiol, fast track status for its intended use in patients with hormone- refractory prostate cancer (HRPC).
› Verified 3 days ago
| Entity Name | Sunnyside Emergency Group A Professional Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033529367 PECOS PAC ID: 0941424451 Enrollment ID: O20140623002600 |
News Archive
Research at New York University is paving the way for a breakthrough that may prevent brain damage in civilians and military troops exposed to poisonous chemicals-particularly those in pesticides and chemical weapons.
Signalife, Inc. has announced that the United States Patent and Trademark Office has awarded the Company a new and important patent entitled "System For, And Method Of, Monitoring Heartbeats Of A Patient". The patent, which covers 37 claims, will enhance the Company's ability to develop new proprietary products.
According to data from the 2005 and 2016 American College of Rheumatology Workforce Studies, a significant increase in the demand for rheumatologists is expected in the coming years. However, the number of trained rheumatologists is declining.
Marshall Edwards today announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anti-cancer drug, phenoxodiol, fast track status for its intended use in patients with hormone- refractory prostate cancer (HRPC).
› Verified 3 days ago
| Entity Name | Olney Emergency Group, A Professional Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386108868 PECOS PAC ID: 8426399965 Enrollment ID: O20190409003071 |
News Archive
Research at New York University is paving the way for a breakthrough that may prevent brain damage in civilians and military troops exposed to poisonous chemicals-particularly those in pesticides and chemical weapons.
Signalife, Inc. has announced that the United States Patent and Trademark Office has awarded the Company a new and important patent entitled "System For, And Method Of, Monitoring Heartbeats Of A Patient". The patent, which covers 37 claims, will enhance the Company's ability to develop new proprietary products.
According to data from the 2005 and 2016 American College of Rheumatology Workforce Studies, a significant increase in the demand for rheumatologists is expected in the coming years. However, the number of trained rheumatologists is declining.
Marshall Edwards today announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anti-cancer drug, phenoxodiol, fast track status for its intended use in patients with hormone- refractory prostate cancer (HRPC).
› Verified 3 days ago
| Entity Name | Ausink Family Medicine Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376268680 PECOS PAC ID: 3274904081 Enrollment ID: O20230113000490 |
News Archive
Research at New York University is paving the way for a breakthrough that may prevent brain damage in civilians and military troops exposed to poisonous chemicals-particularly those in pesticides and chemical weapons.
Signalife, Inc. has announced that the United States Patent and Trademark Office has awarded the Company a new and important patent entitled "System For, And Method Of, Monitoring Heartbeats Of A Patient". The patent, which covers 37 claims, will enhance the Company's ability to develop new proprietary products.
According to data from the 2005 and 2016 American College of Rheumatology Workforce Studies, a significant increase in the demand for rheumatologists is expected in the coming years. However, the number of trained rheumatologists is declining.
Marshall Edwards today announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anti-cancer drug, phenoxodiol, fast track status for its intended use in patients with hormone- refractory prostate cancer (HRPC).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert J Rookstool, MD 4940 Bayview Rd, Langley, WA 98260-9778 Ph: (360) 221-0223 | Dr Robert J Rookstool, MD 1211 24th Street, Island Hospital, Anacortes, WA 98221-4927 Ph: (360) 299-1311 |
News Archive
Research at New York University is paving the way for a breakthrough that may prevent brain damage in civilians and military troops exposed to poisonous chemicals-particularly those in pesticides and chemical weapons.
Signalife, Inc. has announced that the United States Patent and Trademark Office has awarded the Company a new and important patent entitled "System For, And Method Of, Monitoring Heartbeats Of A Patient". The patent, which covers 37 claims, will enhance the Company's ability to develop new proprietary products.
According to data from the 2005 and 2016 American College of Rheumatology Workforce Studies, a significant increase in the demand for rheumatologists is expected in the coming years. However, the number of trained rheumatologists is declining.
Marshall Edwards today announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anti-cancer drug, phenoxodiol, fast track status for its intended use in patients with hormone- refractory prostate cancer (HRPC).
› Verified 3 days ago
Robert Lynn Apter, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1211 24th St, Anacortes, WA 98221 Phone: 360-299-1300 Fax: 253-838-6418 | |
James D. Martin, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1015 25th St, Medical Arts Pavillion, Anacortes, WA 98221 Phone: 360-899-4600 | |
Randolph Wade Juel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1211 24th St, Anacortes, WA 98221 Phone: 360-299-1311 Fax: 360-299-1312 | |
Marykay Pasnick, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1211 24th St, Anacortes, WA 98221 Phone: 360-299-1300 Fax: 360-299-1312 | |
Justin Paul Curran, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1211 24th St, Anacortes, WA 98221 Phone: 360-299-1311 Fax: 360-299-1312 | |
Michael Cooks, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1211 24th St, Anacortes, WA 98221 Phone: 360-299-1300 |